Stay up to date
We are moving fast and shaping the cell & gene landscape requires a lot of engagement amongst all stakeholders in the ecosystem.
We keep you informed about the latest news on Tigen and we would be delighted to get your feedback and your point of view.
News
Lausanne, 26 January 2024
Tigen signs option agreement with Memorial Sloan Kettering Cancer Center (MSK) for the autologous CD371 armored Chimeric Antigen Receptor (CAR) T-cell Technology to advance the
therapy development for relapsed/refractory Acute Myeloid Leukemia (AML).
Lausanne, 18 January 2024
Skills for Scientists meets Tigen at the Biopôle Lausanne - Academic vs. industrial career?
We were welcoming a group of PhD students, postdocs, and researchers from the University of Lausanne - UNIL and the CHUV | Lausanne university hospital in our Tigen office and lab and had an open and lively discussion about the life in academia vs. “the industry”.
Zurich, 16 November 2023
Digital Innovation of the Year! Thanks to SwissICT for awarding this prestigious award to Tigen and ELCA Group for our digital platform to accelerate patient access to cell-based cancer therapies. Thanks also to Microsoft for being all-in. It’s an honor and motivation booster for our teams.
Lausanne, 25 October 2023
Tigen and the Swiss Data Science Center (SDSC) are joining forces to accelerate the AI engine that powers Tigen’s artificial intelligence-based biomanufacturing system for augmented cell & gene therapies. The project is supported by an Innosuisse grant from the Swiss government.
Lausanne, 10 September 2023
Tigen and ELCA collaborate on digital solutions to accelerate the development and supply of T cell-based cancer therapies. ELCA was awarded Microsoft Partner of the Year 2023, also based on our collaboration to advance digital healthcare.
Zurich, 16 August 2023
Tigen and ELCA are shortlisted for the Digital Economy Award 2023, which is hosted by swissICT.
Our joint initiative «Digital Solution to advance T Cell-based Cancer Therapy Development» got recognition in the categories Digital Innovation of the Year and Digital Excellence.
Paris, 1 June 2023
The International Society for Cell & Gene Therapy (ISCT) Paris 2023 conference was full of new insights and great conversations that led to many new contacts in the CGT ecosystem. Tigen's Ursula Busse presented our work on Next Generation TIL Therapies run together with CHUV and Ludwig Institute for Cancer Research.
Lausanne, 31 May 2023
We discovered some new sights of Lausanne last evening. The B2Run Schweizer Firmenlauf gathered an energetic crowd of athletes from small to large companies in the Stade de Pierre de Coubertin.
Boston, 31 May 2023
Therese Choquette from the Tigen analytics team is sharing insights from our development work at the 2nd Cell Therapy Potency Assay Summit in Boston from May 31 - June 2, 2023.
We are curious to discuss with and learn from the CGT analytics community during the pre-conference workshop.